Simmons R, Fajans P, Lubis F
Department of Population Planning and International Health, School of Public Health, University of Michigan, Ann Arbor 48109-2029.
Contraception. 1994 May;49(5):509-25. doi: 10.1016/0010-7824(94)90007-8.
This paper presents a programmatic perspective on the relationship between the introduction of new contraceptive technology and expanding contraceptive options, using the example of Cyclofem in Indonesia. Past approaches to contraceptive introduction have considered only the characteristics of the new method in the decision-making process. In assessing whether the introduction of a new method actually expands contraceptive choice for women and whether the program has the managerial capabilities to assure quality of care in this process, the authors argue that consideration must be given to all methods within a delivery system and how new technology relates to the management of contraceptive choice. Using this perspective, the authors suggest that choice would not necessarily be expanded with scaled-up service delivery of a new once-a month injectable in the Indonesian public sector context.
本文以印度尼西亚的Cyclofem为例，从规划的角度阐述了新避孕技术的引入与扩大避孕选择之间的关系。过去引入避孕方法的方式在决策过程中仅考虑新方法的特性。在评估新方法的引入是否真的为女性扩大了避孕选择，以及该项目在这一过程中是否具备确保护理质量的管理能力时，作者认为必须考虑到一个服务体系内的所有方法，以及新技术与避孕选择管理之间的关系。从这个角度来看，作者认为，在印度尼西亚公共部门的背景下，扩大每月注射一次的新型注射剂的服务提供规模并不一定会扩大选择范围。
